Carregant...

Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

1. In a cross-over study a new low molecular weight heparinoid Org 10172 was administered to 12 elderly male and female volunteers. It was well tolerated and no adverse effects occurred. 2. The absolute bioavailability of Org 10172 as measured by plasma anti-Xa activity, glycosaminoglycuronans with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stiekema, J C, Wijnand, H P, Van Dinther, T G, Moelker, H C, Dawes, J, Vinchenzo, A, Toeberich, H
Format: Artigo
Idioma:Inglês
Publicat: 1989
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379703/
https://ncbi.nlm.nih.gov/pubmed/2468354
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!